Drug:
Reaction: WEIGHT INCREASED
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26518087 |
US |
2 | |
Weight increased, Off label use, Intentional dose omission, |
||||
TIRZEPATIDE, |
||||
| 302 | 26518236 |
US |
||
Increased appetite, Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, |
||||
| 303 | 26518466 |
JP |
56 | 2 |
Sudden hearing loss, Hypertension, Weight increased, Blood creatinine decreased, Blood pressure increased, Diabetes mellitus, Low density lipoprotein increased, Hyperphagia, High density lipoprotein decreased, Hepatic steatosis, Alanine aminotransferase increased, Aspartate aminotransferase increased, Contraindicated product administered, |
||||
PIOGLITAZONE, ROSUVASTATIN, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 304 | 26518817 |
US |
70 | |
Weight increased, Product storage error, |
||||
TIRZEPATIDE, |
||||
| 305 | 26518978 |
EU |
2 | |
Death, Insomnia, Somnolence, Weight increased, Oedema peripheral, Drug interaction, |
||||
PREGABALIN, PREGABALIN, OXYCODONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FUROSEMIDE, MORPHINE, TOPIRAMATE, TOPIRAMATE SPINKLE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, GABAPENTIN, GABAPENTIN, |
||||
| 306 | 26519527 |
US |
77 | 1 |
Ventricular extrasystoles, Condition aggravated, Ventricular extrasystoles, Food craving, Weight increased, Off label use, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 307 | 26519878 |
US |
||
Glycosylated haemoglobin abnormal, COVID-19, Food craving, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 308 | 26520011 |
CA |
43 | 2 |
Pain, Peripheral venous disease, Paraesthesia, Pemphigus, Peripheral swelling, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Maternal exposure during pregnancy, Exposure during pregnancy, Pericarditis, |
||||
SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, PREDNISONE, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LORAZEPAM, RISEDRONATE SODIUM, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LISINOPRIL, |
||||
| 309 | 26520109 |
AU |
27 | |
Weight increased, |
||||
INFLIXIMAB-DYYB, |
||||
| 310 | 26520225 |
EU |
16 | 2 |
Lack of satiety, Anger, Weight increased, Panic attack, Obesity, |
||||
OLANZAPINE, |
||||
| 311 | 26520323 |
US |
2 | |
Type 1 diabetes mellitus, Weight increased, |
||||
LIRAGLUTIDE, |
||||
| 312 | 26520351 |
US |
1 | |
Cerebrovascular accident, Weight increased, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 313 | 26520436 |
US |
28 | 1 |
Weight increased, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
| 314 | 26520515 |
|||
Drug effective for unapproved indication, Wheezing, Weight increased, Headache, Restlessness, Sleep disorder, Fatigue, Off label use, |
||||
RUXOLITINIB, ALBUTEROL SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE MALEATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 315 | 26520610 |
US |
||
Intermenstrual bleeding, Acne, Weight increased, Condition aggravated, |
||||
DROSPIRENONE, |
||||
| 316 | 26520682 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 317 | 26520861 |
CA |
44 | 2 |
Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Joint swelling, Pregnancy, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Synovitis, Weight increased, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 318 | 26520913 |
US |
61 | 2 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 319 | 26521112 |
US |
59 | 2 |
Drug-induced liver injury, Hepatic steatosis, Weight increased, Metabolic dysfunction-associated steatohepatitis, Hepatic fibrosis, |
||||
UPADACITINIB, |
||||
| 320 | 26524190 |
43 | 2 | |
Drug ineffective, Weight increased, Product quality issue, |
||||
ELETRIPTAN HYDROBROMIDE, |
||||
| 321 | 26512445 |
US |
77 | 1 |
Weight increased, |
||||
LUSPATERCEPT, LUSPATERCEPT, |
||||
| 322 | 26512477 |
US |
2 | |
Device breakage, Weight increased, Diarrhoea, |
||||
TREPROSTINIL, SOTATERCEPT-CSRK, |
||||
| 323 | 26512545 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 324 | 26512740 |
GB |
47 | 2 |
Obsessive-compulsive disorder, Compulsive shopping, Medication error, Impulse-control disorder, Weight increased, |
||||
PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
| 325 | 26512747 |
GB |
31 | 2 |
Swelling, Weight increased, Lymphoedema, Fatigue, Peripheral swelling, |
||||
MIRTAZAPINE, |
||||
| 326 | 26512782 |
CA |
40 | 2 |
Abdominal distension, Adverse reaction, Back injury, Bursitis, Coeliac disease, Condition aggravated, Dyspepsia, Fall, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Grip strength decreased, Headache, Hepatitis, Hypoaesthesia, Injury, Insomnia, Intentional product use issue, Liver function test increased, Malaise, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Neck pain, Off label use, Pain in extremity, Pneumonia, Product label confusion, Weight increased, Wheezing, Wound infection, |
||||
SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, CANDESARTAN CILEXETIL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 327 | 26512850 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 328 | 26512944 |
US |
1 | |
Steroid dependence, Hospitalisation, Decreased appetite, Mobility decreased, Skin striae, Weight increased, Aggression, Behaviour disorder, Diarrhoea, Influenza, Intentional product use issue, |
||||
VAMOROLONE, VAMOROLONE, VAMOROLONE, ETEPLIRSEN, BACLOFEN, |
||||
| 329 | 26513114 |
US |
1 | |
Weight increased, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, GABAPENTIN, ALBUTEROL SULFATE, ALBUTEROL, CYANOCOBALAMIN, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 330 | 26513129 |
US |
80 | |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 331 | 26513137 |
US |
81 | 1 |
Decreased appetite, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 332 | 26513210 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 333 | 26513519 |
DZ |
58 | 2 |
Weight increased, Thyroid disorder, |
||||
| 334 | 26513628 |
US |
37 | 2 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 335 | 26514139 |
PK |
55 | 2 |
Weight increased, Disease progression, |
||||
BEVACIZUMAB, BEVACIZUMAB, |
||||
| 336 | 26514308 |
US |
67 | 2 |
Inappropriate schedule of product administration, Product availability issue, Weight increased, |
||||
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, PAROXETINE HYDROCHLORIDE, CLONIDINE, CLONIDINE, |
||||
| 337 | 26514333 |
CA |
30 | |
Defaecation urgency, Colitis ulcerative, Nausea, Palpitations, Intermenstrual bleeding, Abdominal pain, Cytomegalovirus infection, Weight increased, Intentional product use issue, Inappropriate schedule of product administration, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISONE, MESALAMINE, |
||||
| 338 | 26514406 |
EU |
32 | 2 |
Hepatic hydrothorax, Skin hypopigmentation, Abdominal distension, Ear discomfort, Abdominal rigidity, Pain in extremity, Dyspnoea at rest, Pain in jaw, Dyspnoea, Dyspepsia, Headache, Insomnia, Hospitalisation, Gastrointestinal disorder, Cough, Dyspnoea exertional, Weight increased, Pulmonary hypertension, Oxygen saturation decreased, Weight decreased, Vomiting, Fatigue, Diaphragmatic injury, Back pain, Gastrointestinal pain, Myalgia, Nausea, Cold sweat, Hypoglycaemia, Increased appetite, Palpitations, Decreased appetite, Restlessness, Epistaxis, Muscular weakness, Nasopharyngitis, Flushing, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, FUROSEMIDE, TADALAFIL, AMBRISENTAN, |
||||
| 339 | 26514500 |
US |
1 | |
Weight increased, |
||||
DALFAMPRIDINE, DALFAMPRIDINE, CLADRIBINE, |
||||
| 340 | 26514843 |
US |
50 | 2 |
Femur fracture, Fall, Palpitations, Energy increased, Lethargy, Asthenia, Peripheral swelling, Constipation, Malaise, Impaired healing, Anaesthetic complication, Arthralgia, Drug hypersensitivity, Dyspnoea, Anosmia, Osteoporosis, Lymphadenopathy, Deafness, Weight increased, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, CALCIUM CARBONATE, ANTACID, TORSEMIDE, |
||||
| 341 | 26514888 |
US |
2 | |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 342 | 26514899 |
CA |
40 | 2 |
Hepatitis, Wound infection, Headache, Muscular weakness, Back injury, Hypoaesthesia, Gastrointestinal disorder, Weight increased, Folliculitis, Condition aggravated, Pneumonia, Coeliac disease, Liver function test increased, Off label use, Musculoskeletal stiffness, Gait inability, Product label confusion, Injury, Intentional product use issue, Wheezing, Mobility decreased, Insomnia, Adverse reaction, Pain in extremity, Abdominal distension, Fall, Bursitis, Grip strength decreased, Nail disorder, Finger deformity, Gastrooesophageal reflux disease, Neck pain, Dyspepsia, Malaise, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, CANDESARTAN CILEXETIL, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 343 | 26514980 |
EU |
40 | 2 |
Thrombocytopenia, Lymphadenopathy, Weight increased, Headache, Haemoglobin decreased, Psoriasis, Red blood cell sedimentation rate increased, Drug intolerance, Skin disorder, Drug ineffective, |
||||
METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOFACITINIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ABATACEPT, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE, AMLODIPINE, BARICITINIB, |
||||
| 344 | 26515207 |
US |
||
Thyroid disorder, Weight increased, Abdominal distension, Abnormal withdrawal bleeding, |
||||
DROSPIRENONE, |
||||
| 345 | 26515337 |
US |
78 | 2 |
Ketoacidosis, Dehydration, Fall, Ankle fracture, Diabetic retinal oedema, Malabsorption, Weight increased, Decreased appetite, Glycosylated haemoglobin increased, Blood glucose increased, Blood glucose decreased, Injection site haemorrhage, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN ASPART INJECTION, INSULIN ASPART, SEMAGLUTIDE, ORAL SEMAGLUTIDE, EMPAGLIFLOZIN, |
||||
| 346 | 26515404 |
US |
32 | 2 |
Arthritis, Brain fog, Weight increased, |
||||
| 347 | 26516417 |
US |
2 | |
Weight increased, |
||||
PEGVALIASE-PQPZ, |
||||
| 348 | 26516501 |
US |
2 | |
Hospitalisation, Weight increased, Product administration interrupted, |
||||
CANNABIDIOL, CANNABIDIOL, LEVETIRACETAM, GABAPENTIN, |
||||
| 349 | 26516645 |
US |
||
Weight increased, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 350 | 26516813 |
US |
2 | |
Pain, Hot flush, Weight increased, |
||||
RAVULIZUMAB, |
||||
| 351 | 26507704 |
CA |
58 | 2 |
Abdominal discomfort, Back injury, Benign abdominal neoplasm, Benign ovarian tumour, Blood pressure diastolic abnormal, Blood pressure increased, Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Body temperature decreased, Chills, Drug hypersensitivity, Fungal infection, Gait disturbance, Human papilloma virus test positive, Impaired healing, Infection, Influenza, Lip injury, Lower respiratory tract congestion, Migraine, Musculoskeletal stiffness, Nasopharyngitis, Oral herpes, Oral herpes, Oral herpes, Oral herpes, Oral pain, Oropharyngeal pain, Ovarian cyst, Oxygen saturation decreased, Pneumonia, Productive cough, Rheumatoid arthritis, Rhinorrhoea, Skin fissures, Sneezing, Stomatitis, Stomatitis, Tinnitus, Ulcer, Upper respiratory tract infection, Drug interaction, Back pain, Malaise, Gastrooesophageal reflux disease, Cough, Hepatic enzyme increased, Infusion related reaction, Nausea, Nausea, Pain, Paraesthesia, Weight decreased, Weight increased, Arthralgia, Drug ineffective, |
||||
PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, |
||||
| 352 | 26507848 |
US |
54 | 1 |
Viral pericarditis, Fatigue, Weight increased, Drug effective for unapproved indication, Impaired quality of life, Off label use, |
||||
PREDNISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, COLCHICINE, |
||||
| 353 | 26507864 |
US |
||
Weight increased, Medication error, |
||||
| 354 | 26508261 |
US |
2 | |
Increased appetite, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 355 | 26508443 |
IN |
48 | 1 |
Irritability, Asthenia, Hypoaesthesia, Gastrointestinal disorder, Dyspnoea, Prescription drug used without a prescription, Drug level above therapeutic, Confusional state, Generalised oedema, Withdrawal syndrome, Intentional product misuse, Drug dependence, Drug abuse, Wheezing, Headache, Sleep disorder, Depressed mood, Weight increased, Paraesthesia, |
||||
PREGABALIN, PREGABALIN, |
||||
| 356 | 26508692 |
CA |
44 | 2 |
Rash, Pruritus, Pyrexia, Drug hypersensitivity, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Blister, Decreased appetite, Discomfort, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, |
||||
| 357 | 26509017 |
US |
||
Heart valve incompetence, Weight increased, Prescription drug used without a prescription, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SUVOREXANT, |
||||
| 358 | 26509204 |
EU |
48 | 2 |
Weight increased, |
||||
| 359 | 26509559 |
AU |
84 | 1 |
Hypervolaemia, Weight increased, Sepsis, Hypoxia, Urine output decreased, Oxygen saturation decreased, Respiratory rate increased, Anuria, Acute pulmonary oedema, Idiopathic environmental intolerance, Blood creatinine increased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, MESNA, MESNA INJECTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, TAMSULOSIN HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, RABEPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 360 | 26509732 |
US |
2 | |
Fatigue, Weight increased, |
||||
TOCILIZUMAB, |
||||
| 361 | 26510324 |
US |
51 | 1 |
Weight increased, Hunger, Wrong technique in product usage process, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 362 | 26510931 |
CA |
67 | 2 |
Cardiac failure, Lung disorder, Dyspnoea, Bedridden, Blood pressure increased, Oedema peripheral, Weight increased, Hypervolaemia, Orthopnoea, Oedema, Skin abrasion, Peripheral swelling, Arthralgia, Back pain, Headache, Musculoskeletal chest pain, Swelling, Confusional state, Weight decreased, Memory impairment, Disorientation, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TRANDOLAPRIL, TRANDOLAPRIL TABLETS, TRANDOLAPRIL, TRANDOLAPRIL TABLETS, PROCHLORPERAZINE, TEMOZOLOMIDE, BISOPROLOL FUMARATE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, CICLESONIDE, IPRATROPIUM BROMIDE AND ALBUTEROL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ERGOCALCIFEROL, |
||||
| 363 | 26511671 |
2 | ||
Bronchitis, Weight increased, Hypoaesthesia, Paraesthesia, Dizziness, Pain in extremity, Arthralgia, |
||||
IRON SUCROSE, IRON SUCROSE, IRON SUCROSE, IRON SUCROSE, |
||||
| 364 | 26511912 |
EU |
2 | |
Death, Insomnia, Somnolence, Weight increased, Oedema peripheral, Drug interaction, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, PREGABALIN, MORPHINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FUROSEMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, GABAPENTIN, GABAPENTIN, |
||||
| 365 | 26515786 |
58 | 2 | |
Weight increased, |
||||
SECUKINUMAB, |
||||
| 366 | 26503019 |
IN |
23 | 2 |
Pre-eclampsia, Oligohydramnios, Premature labour, Drug dose titration not performed, Weight increased, Maternal exposure during pregnancy, |
||||
OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, RISPERIDONE, RISPERIDONE, FOLIC ACID, CALCIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 367 | 26503414 |
US |
||
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, |
||||
| 368 | 26503491 |
CA |
44 | |
C-reactive protein, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Malaise, Mobility decreased, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Folliculitis, Helicobacter infection, Infection, Sinusitis, Intentional product use issue, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREPITANT, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CYANOCOBALAMIN, CYANOCOBALAMIN, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, OXYCODONE, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, PREGABALIN, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIMETHOPRIM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 369 | 26503704 |
US |
66 | 2 |
Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, THYROID, PORCINE, |
||||
| 370 | 26504118 |
US |
||
IIIrd nerve paralysis, Idiopathic intracranial hypertension, Eyelid ptosis, Papilloedema, Weight increased, |
||||
RISPERIDONE, |
||||
| 371 | 26504306 |
BR |
19 | 1 |
Weight increased, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 372 | 26504478 |
US |
62 | 2 |
Illness, Weight increased, Fatigue, Sinusitis, Glycosylated haemoglobin increased, Vitreous floaters, Flatulence, Nausea, |
||||
UPADACITINIB, SEMAGLUTIDE, |
||||
| 373 | 26504594 |
CA |
||
Neoplasm malignant, Viral load increased, Weight increased, Drug interaction, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 374 | 26504846 |
US |
35 | 2 |
Gastrointestinal sounds abnormal, Weight increased, Drug ineffective, Hyperphagia, Increased appetite, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 375 | 26505167 |
CA |
2 | |
Weight increased, Wheezing, Wound, Wound infection, |
||||
AZATHIOPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MESALAMINE, TRAMADOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, CLONIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ALENDRONATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TOFACITINIB, TOFACITINIB CITRATE, |
||||
| 376 | 26505211 |
US |
16 | 2 |
IIIrd nerve paralysis, Weight increased, |
||||
RISPERIDONE, |
||||
| 377 | 26505268 |
US |
2 | |
Mood altered, Hypoglycaemia, Blood glucose fluctuation, Hepatic function abnormal, Glycosylated haemoglobin increased, Blood glucose increased, Dizziness, Weight increased, Overdose, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, VILAZODONE HYDROCHLORIDE, |
||||
| 378 | 26505346 |
BR |
42 | 2 |
Weight increased, |
||||
INFLIXIMAB, |
||||
| 379 | 26505453 |
US |
82 | 2 |
Cyst, Weight increased, Off label use, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 380 | 26505539 |
PK |
38 | 1 |
Ascites, Weight increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 381 | 26505826 |
US |
47 | 2 |
Weight increased, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 382 | 26505847 |
CA |
63 | 2 |
Vitamin B12 decreased, Back pain, Ear infection, Ear pain, Facet joint syndrome, Fall, General physical health deterioration, Hand fracture, Impetigo, Inappropriate schedule of product administration, Joint dislocation, Lower respiratory tract infection, Scoliosis, Tendon rupture, Tooth fracture, Upper limb fracture, Weight decreased, Weight increased, Drug hypersensitivity, |
||||
CYANOCOBALAMIN, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, CANNABIDIOL, CANNABIDIOL, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, |
||||
| 383 | 26505908 |
AU |
51 | 2 |
Colitis, Weight increased, Blood cholesterol increased, Off label use, Off label use of device, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 384 | 26506021 |
40 | 2 | |
Multiple sclerosis relapse, Swelling, Hunger, Weight increased, |
||||
| 385 | 26506040 |
US |
44 | 2 |
Incorrect dose administered, Off label use, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 386 | 26506484 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 387 | 26506710 |
2 | ||
Weight increased, |
||||
LEVONORGESTREL, |
||||
| 388 | 26506802 |
EU |
40 | 2 |
Thrombocytopenia, Lymphadenopathy, Weight increased, Headache, Haemoglobin decreased, Psoriasis, Red blood cell sedimentation rate increased, Drug ineffective, Drug intolerance, Skin disorder, |
||||
ABATACEPT, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, TOFACITINIB, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE, AMLODIPINE, BARICITINIB, |
||||
| 389 | 26506838 |
US |
66 | |
Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 390 | 26506867 |
US |
2 | |
Weight increased, Swelling, Nasopharyngitis, Illness, Gastrooesophageal reflux disease, Nausea, Decreased appetite, Abdominal pain lower, Flank pain, |
||||
VELAGLUCERASE ALFA, EPINEPHRINE, ADRENALINUM, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FOLIC ACID, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, METHOTREXATE, METHOTREXATE SODIUM, LIDOCAINE, METHYLPREDNISOLONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ONDANSETRON HYDROCHLORIDE, CELECOXIB, DICYCLOMINE HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, MOMETASONE FUROATE, ALBUTEROL SULFATE, BUDESONIDE, CYANOCOBALAMIN, MAGNESIUM OXIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 391 | 26507114 |
US |
2 | |
Constipation, Metabolic disorder, Weight increased, Pain, Food craving, Blood pressure increased, Blood glucose increased, Anal incontinence, General physical health deterioration, Asthenia, Hyperphagia, Feeling abnormal, Dyspepsia, Gastric dilatation, Abdominal distension, Fluid retention, Drug ineffective, Product use issue, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ESCITALOPRAM, |
||||
| 392 | 26507461 |
US |
33 | 1 |
Diabetes mellitus, Drug effective for unapproved indication, Weight increased, Off label use, |
||||
PREDNISONE, PREDNISONE, |
||||
| 393 | 26498164 |
US |
1 | |
Pulpitis dental, Periodontitis, Arthralgia, Weight increased, Constipation, Hot flush, Tooth resorption, Dental caries, |
||||
RELUGOLIX, VITAMIN C, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOXAZOSIN, DOXAZOSIN MESYLATE, AZELASTINE, METOPROLOL TARTRATE, METOPROLOL, LIFITEGRAST, VALSARTAN, VALSARTAN ORAL, GABAPENTIN, |
||||
| 394 | 26498234 |
US |
2 | |
Vomiting, Eye pruritus, Weight increased, Eyelid rash, Erythema, Peripheral swelling, Nausea, Rash, |
||||
PIMAVANSERIN TARTRATE, ALPRAZOLAM, ZOLPIDEM TARTRATE, ATROPINE SULFATE, ATROPINE SULFATE MONOHYDRATE, ATROPINE SULFATE INJECTION, IBANDRONATE SODIUM, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, LEVODOPA, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, LORATADINE, LORATADINE ORAL, POLYETHYLENE GLYCOL 3350, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, FOSCARBIDOPA/FOSLEVODOPA, ALPRAZOLAM, ZOLPIDEM TARTRATE, |
||||
| 395 | 26498251 |
US |
47 | 2 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 396 | 26498270 |
US |
1 | |
Hallucination, Weight increased, |
||||
PIMAVANSERIN TARTRATE, ALPRAZOLAM, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, EPINEPHRINE, ADRENALINUM, TIZANIDINE HYDROCHLORIDE, MELATONIN, POLYETHYLENE GLYCOL 3350, ROSUVASTATIN CALCIUM, AMANTADINE, SERTRALINE HYDROCHLORIDE, RIVASTIGMINE, MAGNESIUM, SERTRALINE HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 397 | 26498445 |
EU |
7 | 1 |
Drug ineffective, Weight increased, Agitation, Neurotoxicity, Hypertriglyceridaemia, Off label use, Irritability, Hypercholesterolaemia, |
||||
CARBOPLATIN, THIOTEPA, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, LOMUSTINE, METHOTREXATE, METHOTREXATE SODIUM, ETOPOSIDE, LORLATINIB, LORLATINIB, LORLATINIB, CISPLATIN, |
||||
| 398 | 26498807 |
CA |
1 | |
Impulse-control disorder, Weight increased, Depression, Drug ineffective, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, RISPERIDONE, |
||||
| 399 | 26499091 |
US |
75 | 2 |
Bone disorder, Weight increased, |
||||
RIPRETINIB, RIPRETINIB, |
||||
| 400 | 26499347 |
US |
43 | 2 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28